Literature DB >> 16479009

Androgen and its receptor promote Bax-mediated apoptosis.

Yuting Lin1, John Kokontis, Fangming Tang, Bradley Godfrey, Shutsung Liao, Anning Lin, Youting Chen, Jialing Xiang.   

Abstract

Androgen and its receptor (AR) have been reported to have pro- or antiapoptotic functions. However, the underlying molecular mechanism is incompletely understood. We report here that androgen and AR promote Bax-mediated apoptosis in prostate cancer cells. UV irradiation and ectopic expression of Bax induce apoptosis in AR-positive, but not AR-negative prostate cancer cells. UV- and Bax-induced apoptosis is abrogated in AR-positive cells that express small interference RNA (siRNA) of AR and is sensitized by reintroduction of AR into AR-negative cells. Although AR is able to promote Bax-mediated apoptosis independently of androgen, the promotion by AR can be further potentiated by androgen via AR-dependent transcription activation. AR is essential for the translocation of Bax to mitochondria in UV- or Bax-induced apoptosis. Inhibition of Bax expression by Bax siRNA suppresses UV-induced apoptosis in AR-positive cells. In addition, introduction of AR into AR-negative prostate cancer cells upregulates expression levels of the BH3-only protein Noxa, whereas inhibition of Noxa expression reduces the promotion by AR on UV-induced apoptosis. Thus, our results reveal a novel cross talk between the androgen/AR hormonal signaling pathway and the intrinsic apoptotic death pathway that determines the sensitivity of stress-induced apoptosis in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479009      PMCID: PMC1430231          DOI: 10.1128/MCB.26.5.1908-1916.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

Review 1.  BCL-2 family members and the mitochondria in apoptosis.

Authors:  A Gross; J M McDonnell; S J Korsmeyer
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

2.  The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA.

Authors:  Pierre-François Cartron; Tristan Gallenne; Gwenola Bougras; Fabien Gautier; Florence Manero; Patricia Vusio; Khaled Meflah; François M Vallette; Philippe Juin
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

3.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.

Authors:  Tomomi Kuwana; Lisa Bouchier-Hayes; Jerry E Chipuk; Christine Bonzon; Barbara A Sullivan; Douglas R Green; Donald D Newmeyer
Journal:  Mol Cell       Date:  2005-02-18       Impact factor: 17.970

4.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

5.  Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.

Authors:  M J Linja; K J Savinainen; O R Saramäki; T L Tammela; R L Vessella; T Visakorpi
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

6.  Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.

Authors:  X Li; M Marani; J Yu; B Nan; J A Roth; S Kagawa; B Fang; L Denner; M Marcelli
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

7.  Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax.

Authors:  T H Kim; Y Zhao; M J Barber; D K Kuharsky; X M Yin
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

8.  Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells.

Authors:  Junichi Fukuchi; Richard A Hiipakka; John M Kokontis; Stephen Hsu; Andrew L Ko; Michael L Fitzgerald; Shutsung Liao
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

9.  Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.

Authors:  M O Joly-Pharaboz; A Ruffion; A Roch; L Michel-Calemard; J André; J Chantepie; B Nicolas; G Panaye
Journal:  J Steroid Biochem Mol Biol       Date:  2000 Jul-Aug       Impact factor: 4.292

10.  Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.

Authors:  Scott A Oakes; Luca Scorrano; Joseph T Opferman; Michael C Bassik; Mari Nishino; Tullio Pozzan; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-21       Impact factor: 11.205

View more
  27 in total

Review 1.  Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.

Authors:  Simeng Wen; Yuanjie Niu; Soo Ok Lee; Chawnshang Chang
Journal:  Cancer Treat Rev       Date:  2013-08-07       Impact factor: 12.111

Review 2.  "No Turning Bax" in the combined battle against prostate cancer:.

Authors:  Ramji R Rajendran; Gary D Kao
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

3.  Proteasomal degradation unleashes the pro-death activity of androgen receptor.

Authors:  Bradley Godfrey; Yuting Lin; Jeffery Larson; Bonnie Haferkamp; Jialing Xiang
Journal:  Cell Res       Date:  2010-05-18       Impact factor: 25.617

4.  Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.

Authors:  Janet K Hess-Wilson; Hannah K Daly; William A Zagorski; Christopher P Montville; Karen E Knudsen
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

5.  Novel role of androgens in mitochondrial fission and apoptosis.

Authors:  Vivek Choudhary; Ismail Kaddour-Djebbar; Vijayabaskar Lakshmikanthan; Taghreed Ghazaly; Gagan Singh Thangjam; Arun Sreekumar; Ronald W Lewis; Ian G Mills; Wendy B Bollag; M Vijay Kumar
Journal:  Mol Cancer Res       Date:  2011-07-01       Impact factor: 5.852

6.  Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

Authors:  Li Yan Khor; Jennifer Moughan; Tahseen Al-Saleem; Elizabeth H Hammond; Varagur Venkatesan; Seth A Rosenthal; Mark A Ritter; Howard M Sandler; Gerald E Hanks; William U Shipley; Alan Pollack
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

7.  Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.

Authors:  Boris Risek; Piotr Bilski; Annette B Rice; William T Schrader
Journal:  Mol Endocrinol       Date:  2008-06-18

8.  Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.

Authors:  Pranjal Kulshreshtha; Anurupa Chakraborty; Lc Singh; Ashwani K Mishra; Dinesh Bhatnagar; Sunita Saxena
Journal:  World J Surg Oncol       Date:  2010-08-04       Impact factor: 2.754

9.  A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

Authors:  Russell Szmulewitz; Supriya Mohile; Edwin Posadas; Rangesh Kunnavakkam; Theodore Karrison; Elizabeth Manchen; Walter M Stadler
Journal:  Eur Urol       Date:  2009-02-27       Impact factor: 20.096

10.  Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.

Authors:  Yuting Lin; Ziyan Lu; John Kokontis; Jialing Xiang
Journal:  Biochem Biophys Res Commun       Date:  2012-11-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.